About
The Experts
Webinars & Conferences
Blog
Events
Talk to an expert
JOIN US
My account
- Logout

Loading...

Webinars

You are here:Home-Webinars

Coming up next:

Infection models for antimicrobial R&D: Intracellular models — Infection models for antimicrobial R&D: Intracellular models
9 July 2019

Find out how GARDP is redoubling its efforts to accelerate the development and delivery of new and improved antibiotics — Find out how GARDP is redoubling its efforts to accelerate the development and delivery of new and improved antibiotics
26 June 2019

Models for antimicrobial R&D: Development and use of in vivo models for infectious disease research — Models for antimicrobial R&D: Development and use of in vivo models for infectious disease research
11 June 2019

Mining Chemical Libraries for New Antibacterials – Session 2 — Mining Chemical Libraries for New Antibacterials – Session 2
4 June 2019

Mining Chemical Libraries for New Antibacterials — Mining Chemical Libraries for New Antibacterials
21 May 2019

<br>Antibacterial drugs: Clinical development for non-developers </br> Part 3: Non-traditional approaches — Antibacterial drugs: Clinical development for non-developers Part 3: Non-traditional approaches
28 March 2019

<br>NIAID Resources to Facilitate Discovery & Development </br>of Anti-Infectives — NIAID Resources to Facilitate Discovery & Development of Anti-Infectives
21 February 2019

Making Safety a Part of Drug Design — Making Safety a Part of Drug Design
13 November 2018

<br>Antibacterial drugs: Clinical development for non-developers </br> Part 2: Development of antibacterial drugs targeting specific pathogens — Antibacterial drugs: Clinical development for non-developers Part 2: Development of antibacterial drugs targeting specific pathogens
11 September 2018

PK-PD in support of accelerated programmes for antimicrobial development: how much is enough? — PK-PD in support of accelerated programmes for antimicrobial development: how much is enough?
26 June 2018

<br>Antibacterial drugs: Clinical development for non-developers </br> Part 1: Traditional development – tiers A and B — Antibacterial drugs: Clinical development for non-developers Part 1: Traditional development – tiers A and B
13 June 2018

« Previous
1
2

Share

Facebook Twitter LinkedIn Reddit Email

REVIVE

REVIVE is a space for everybody with an interest in antimicrobial R&D.

The Global Antibiotic Research & Development Partnership (GARDP) aims to develop and deliver new treatments for bacterial infections where drug resistance is present or emerging, or for which inadequate treatment exists, while endeavouring to ensure sustainable access.

Content

Blog (17)
Conferences (16)
Experts (62)
External webinars (12)
Webinars (23)

Search site

Search for:

CONNECT

Twitter
LinkedIn
YouTube

GARDP
DNDi

© All Rights Reserved

Privacy Policy | Terms of Use | Acceptable Use Policy | Cookie Policy

We use cookies to improve your experience with our website. By continuing to browse our website, you are agreeing to our use of cookies. However, you can change your cookie settings at any time in your browser.
Read our cookie policy